Interest in Sanofi’s Consumer Health Division Peaks Among Top Buyout Firms
Buyout Firms Eyeing Sanofi’s Consumer Health Division
Advent International and Blackstone Group Inc. are among the prominent buyout firms showing keen interest in Sanofi’s consumer health division, as reported by Bloomberg on Tuesday. The division, which is listed on Nasdaq, has been attracting significant attention from potential investors, leading to a more than 2% surge in Sanofi’s shares on Tuesday.
Sanofi’s Plans to Separate Consumer Health Division
Sanofi, a renowned French pharmaceutical giant, unveiled its intentions to separate the consumer health division in October. The division, known for selling over-the-counter products such as Phytoxil cough syrups and Icy Hot pain relief gels, has piqued the interest of major players in the private equity space, including Bain Capital, CVC Capital Partners, EQT AB, and KKR & Co.
Valuation and Potential Sale
According to Bloomberg’s sources, the division could potentially be valued at around $20 billion in any deal. Sanofi has expressed its openness to a sale if the unit can be sold for its desired valuation. However, the company may also consider retaining a stake in the business as part of any agreement. It’s important to note that the discussions are still in the early stages, with no guarantee of formal proposals by the private equity firms at this time.
